Beck Bode’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
Beck Bode's DGX Position: Q3 2026 in Review
Beck Bode increased its Quest Diagnostics (DGX) stake by 9.5% in Q3 2026, buying an estimated $38.4K and bringing the position to 1,917 shares worth $447K. The position accounts for 0.07% of the portfolio, ranked #66.
Beck Bode first reported a position in DGX in Q3 2020 and has held it in 6 quarters since. The position peaked at $455K in Q3 2021. 978 funds tracked by Wall St. Rank hold DGX as of Q3 2026.
- Beck Bode held 1,917 shares of Quest Diagnostics worth $447K as of Q3 2026.
- Beck Bode bought 166 Quest Diagnostics shares in Q3 2026, an estimated $38.4K.
- Quest Diagnostics made up 0.07% of Beck Bode's portfolio in Q3 2026, its #66 holding.
- Beck Bode first reported a position in Quest Diagnostics in Q3 2020 and has held it in 6 quarters since.
- Beck Bode's Quest Diagnostics position peaked at $455K in Q3 2021.
- 978 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2026.
Based on Beck Bode's 13F filing for Q3 2026, filed 12 Nov 2026.